-
1
-
-
17644427902
-
-
American Cancer Society:, Atlanta, GA, American Cancer Society
-
American Cancer Society: Cancer Facts and Figures 2006. Atlanta, GA, American Cancer Society, 2006
-
(2006)
Cancer Facts and Figures 2006
-
-
-
2
-
-
0027917369
-
Clinical trials in testicular cancer
-
Einhorn LH: Clinical trials in testicular cancer. Cancer 71:3182-3184, 1993
-
(1993)
Cancer
, vol.71
, pp. 3182-3184
-
-
Einhorn, L.H.1
-
3
-
-
0027462641
-
Surgical salvage of chemotherapy refractory germ cell tumors
-
Murphy B, Breeden ES, Donohue JP, et al: Surgical salvage of chemotherapy refractory germ cell tumors. J Clin Oncol 11:324-329, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 324-329
-
-
Murphy, B.1
Breeden, E.S.2
Donohue, J.P.3
-
4
-
-
0023695848
-
Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide
-
Loehrer PJ Sr, Lauer R, Roth BJ, et al: Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109:540-546, 1988
-
(1988)
Ann Intern Med
, vol.109
, pp. 540-546
-
-
Loehrer Sr, P.J.1
Lauer, R.2
Roth, B.J.3
-
5
-
-
0344734200
-
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor
-
Loehrer PJ Sr, Gonin R, Nichols CR, et al: Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16:2500-2504, 1998
-
(1998)
J Clin Oncol
, vol.16
, pp. 2500-2504
-
-
Loehrer Sr, P.J.1
Gonin, R.2
Nichols, C.R.3
-
6
-
-
27244441799
-
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
-
Kondagunta GV, Bacik J, Donadio A, et al: Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549-6555, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 6549-6555
-
-
Kondagunta, G.V.1
Bacik, J.2
Donadio, A.3
-
7
-
-
0034306291
-
High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer
-
Bhatia S, Abonour R, Porcu P, et al: High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 18:3346-3352, 2000
-
(2000)
J Clin Oncol
, vol.18
, pp. 3346-3352
-
-
Bhatia, S.1
Abonour, R.2
Porcu, P.3
-
8
-
-
0036534301
-
A phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group
-
Hinton S, Catalano P, Einhorn LH, et al: A phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 20:1859-1863, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 1859-1863
-
-
Hinton, S.1
Catalano, P.2
Einhorn, L.H.3
-
9
-
-
0028200671
-
Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience
-
Saxman SB, Nichols CR, Einhorn LH: Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience. J Clin Oncol 12:1390-1393, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 1390-1393
-
-
Saxman, S.B.1
Nichols, C.R.2
Einhorn, L.H.3
-
10
-
-
0035868955
-
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results or an international multicenter analysis
-
Hartmann JT, Einhorn L, Nichols CR, et al: Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results or an international multicenter analysis. J Clin Oncol 19:1641-1648, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 1641-1648
-
-
Hartmann, J.T.1
Einhorn, L.2
Nichols, C.R.3
-
11
-
-
0031041148
-
Late relapse of germ cell tumors after cisplatin-based chemotherapy
-
Gerl A, Clemm C, Schmeller N, et al: Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 8:41-47, 1997
-
(1997)
Ann Oncol
, vol.8
, pp. 41-47
-
-
Gerl, A.1
Clemm, C.2
Schmeller, N.3
-
12
-
-
0029003920
-
Late relapse of testicular cancer
-
Baniel J, Foster RS, Gonin R, et al: Late relapse of testicular cancer. J Clin Oncol 13:1170-1176, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 1170-1176
-
-
Baniel, J.1
Foster, R.S.2
Gonin, R.3
-
13
-
-
27244438586
-
Incidence of late-relapse germ cell tumor and outcome to salvage therapy
-
Ronnen EA, Kondagunta GV, Bacik J, et al: Incidence of late-relapse germ cell tumor and outcome to salvage therapy. J Clin Oncol 23:6999-7004, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 6999-7004
-
-
Ronnen, E.A.1
Kondagunta, G.V.2
Bacik, J.3
-
14
-
-
0034018538
-
Results of treatment after relapse from high-dose chemotherapy in germ cell tumors
-
Porcu P, Bahtia S, Sharma M, et al: Results of treatment after relapse from high-dose chemotherapy in germ cell tumors. J Clin Oncol 18:1181-1186, 2000
-
(2000)
J Clin Oncol
, vol.18
, pp. 1181-1186
-
-
Porcu, P.1
Bahtia, S.2
Sharma, M.3
-
15
-
-
0025141586
-
A phase II study of daily oral etoposide in refractory germ cell tumors
-
Miller JC, Einhorn LH: A phase II study of daily oral etoposide in refractory germ cell tumors. Semin Oncol 17:36-39, 1990
-
(1990)
Semin Oncol
, vol.17
, pp. 36-39
-
-
Miller, J.C.1
Einhorn, L.H.2
-
16
-
-
0015380003
-
Clinical use of adriamycin in advanced testicular cancer
-
Monfardini S, Bajetta E, Musumeci R, et al: Clinical use of adriamycin in advanced testicular cancer. J Urol 108:293-296, 1972
-
(1972)
J Urol
, vol.108
, pp. 293-296
-
-
Monfardini, S.1
Bajetta, E.2
Musumeci, R.3
-
17
-
-
0017328320
-
Improved chemotherapy in disseminated testicular cancer
-
Einhorn LH, Donohue JP: Improved chemotherapy in disseminated testicular cancer. J Urol 117:65-69, 1977
-
(1977)
J Urol
, vol.117
, pp. 65-69
-
-
Einhorn, L.H.1
Donohue, J.P.2
-
18
-
-
0017653469
-
Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer
-
Higby DJ, Wallace HJ, Henderson ES, et al: Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer. Cancer Treat Rep 61:869-873, 1977
-
(1977)
Cancer Treat Rep
, vol.61
, pp. 869-873
-
-
Higby, D.J.1
Wallace, H.J.2
Henderson, E.S.3
-
19
-
-
0017073635
-
Combination chemotherapy with adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases
-
Vogl SE, Ohnuma T, Perloff M, et al: Combination chemotherapy with adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases. Cancer 38:21-26, 1976
-
(1976)
Cancer
, vol.38
, pp. 21-26
-
-
Vogl, S.E.1
Ohnuma, T.2
Perloff, M.3
-
20
-
-
0019494152
-
The role of maintenance therapy in disseminated testicular cancer
-
Einhorn LH, Williams SD, Troner M, et al: The role of maintenance therapy in disseminated testicular cancer. N Engl J Med 305:727-731, 1981
-
(1981)
N Engl J Med
, vol.305
, pp. 727-731
-
-
Einhorn, L.H.1
Williams, S.D.2
Troner, M.3
-
21
-
-
0021016115
-
Chemotherapy of refractory germ cell cancer with etoposide
-
Lederman GS, Garnick MB, Canellos GP, et al: Chemotherapy of refractory germ cell cancer with etoposide. J Clin Oncol 11:706-709, 1983
-
(1983)
J Clin Oncol
, vol.11
, pp. 706-709
-
-
Lederman, G.S.1
Garnick, M.B.2
Canellos, G.P.3
-
22
-
-
0026751953
-
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: A phase II study
-
Stoter G, Akdas A, Fossa SD, et al: High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: A phase II study. Ann Oncol 3:577-578, 1992
-
(1992)
Ann Oncol
, vol.3
, pp. 577-578
-
-
Stoter, G.1
Akdas, A.2
Fossa, S.D.3
-
23
-
-
84871470235
-
A phase II trial of epirubicin (EPI) in the salvage therapy of germ cell tumours
-
abstr 388
-
Schultz SM, Loehrer P, Williams S, et al: A phase II trial of epirubicin (EPI) in the salvage therapy of germ cell tumours. Proc Am Soc Clin Oncol 6:99, 1987 (abstr 388)
-
(1987)
Proc Am Soc Clin Oncol
, vol.6
, pp. 99
-
-
Schultz, S.M.1
Loehrer, P.2
Williams, S.3
-
24
-
-
12644293443
-
Phase II trial with single agent epirubicin (EPI) as salvage chemotherapy (CT) in refractory germ cell tumours (RGCT)
-
abstr 563
-
Lecesne A, Droz JP, Azab M, et al: Phase II trial with single agent epirubicin (EPI) as salvage chemotherapy (CT) in refractory germ cell tumours (RGCT). Proc Am Soc Clin Oncol 9:145, 1990 (abstr 563)
-
(1990)
Proc Am Soc Clin Oncol
, vol.9
, pp. 145
-
-
Lecesne, A.1
Droz, J.P.2
Azab, M.3
-
25
-
-
0025035342
-
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study
-
Harstrick A, Schmoll HJ, Wilke H, et al: High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study. Ann Oncol 1:375-376, 1990
-
(1990)
Ann Oncol
, vol.1
, pp. 375-376
-
-
Harstrick, A.1
Schmoll, H.J.2
Wilke, H.3
-
26
-
-
0036231815
-
A 20% dose reduction of the original CISCAA/B regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: Final results of a phase III randomized trial
-
Fizazi K, Do KA, Wang X, el al: A 20% dose reduction of the original CISCAA/B regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: Final results of a phase III randomized trial. Ann Oncol 113:125-134, 2002
-
(2002)
Ann Oncol
, vol.113
, pp. 125-134
-
-
Fizazi, K.1
Do, K.A.2
Wang, X.3
el al4
-
27
-
-
0030052587
-
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
-
Bokemeyer C, Beyer J, Metzner B, et al: Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 7:31-34, 1996
-
(1996)
Ann Oncol
, vol.7
, pp. 31-34
-
-
Bokemeyer, C.1
Beyer, J.2
Metzner, B.3
-
28
-
-
0032055188
-
A phase II trial of paclitaxel in refractory germ cell tumors
-
Sandler AB, Cnstou A, Fox S, et al: A phase II trial of paclitaxel in refractory germ cell tumors. Cancer 82:1381-1386, 1998
-
(1998)
Cancer
, vol.82
, pp. 1381-1386
-
-
Sandler, A.B.1
Cnstou, A.2
Fox, S.3
-
29
-
-
0033015208
-
Phase II trial of gemcitabine in refractory germ cell tumors
-
Einhorn LH, Stender MJ, Williams SD, et al: Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol 17:509-511, 1999
-
(1999)
J Clin Oncol
, vol.17
, pp. 509-511
-
-
Einhorn, L.H.1
Stender, M.J.2
Williams, S.D.3
-
30
-
-
0033044108
-
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer
-
Bokemeyer C, Gerl A, Schoffski P, et al: Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 17:512-516, 1999
-
(1999)
J Clin Oncol
, vol.17
, pp. 512-516
-
-
Bokemeyer, C.1
Gerl, A.2
Schoffski, P.3
-
31
-
-
0037089634
-
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: A study of the German Testicular Cancer Study Group
-
Kollmannsberger C, Rick O, Dengs HG, et al: Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 20:2031-2037, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 2031-2037
-
-
Kollmannsberger, C.1
Rick, O.2
Dengs, H.G.3
-
32
-
-
3142577828
-
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group
-
Kollmannsberger C, Beyer J, Liersch R, et al: Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 22:108-114, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 108-114
-
-
Kollmannsberger, C.1
Beyer, J.2
Liersch, R.3
|